Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_assertion type Assertion NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_head.
- NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_assertion description "[Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO+) CD4+ T cells in the blood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_provenance.
- NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_assertion evidence source_evidence_literature NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_provenance.
- NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_assertion SIO_000772 11037980 NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_provenance.
- NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_assertion wasDerivedFrom befree-20150227 NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_provenance.
- NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_assertion wasGeneratedBy ECO_0000203 NP878722.RAOsJyL_YBkB88eD-GsZ10HXUrEuOsmXPDUIenIZKbU-c130_provenance.